A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Condition: Hypertension · Sponsor: Mineralys Therapeutics Inc.
About this study
A Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat an aldosterone synthase inhibitor (ASI), administered as an add-on to a standardized anti-hypertensive (AHT) medication regimen, in subjects with hypertension.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (104)
| Cardiology, P.C. - Birmingham | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham (UAB) - Vascular Biology and Hypertension Program | Birmingham, Alabama, United States | — |
| Chandler Clinical Trials | Chandler, Arizona, United States | — |
| Brown Road Family Medicine | Mesa, Arizona, United States | — |
| Scottsdale Clinical Trials (Elite Clinical Network) | Scottsdale, Arizona, United States | — |
| Fiel Family & Sports Medicine | Tempe, Arizona, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | — |
| The Medical Research Group Inc. | Fresno, California, United States | — |
| Marvel Clinical Research | Huntington Beach, California, United States | — |
| University of California San Diego (UCSD) - Altman Clinical and Translational Research Institute (ACTRI) | La Jolla, California, United States | — |
| Clinical Trials Research | Lincoln, California, United States | — |
+ 92 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05769608